Published in Atherosclerosis on June 01, 2001
Ethnic differences in cardiovascular disease. Heart (2003) 1.96
Relation between soluble intercellular adhesion molecule-1, homocysteine, and fibrinogen levels and race/ethnicity in women without cardiovascular disease. Am J Cardiol (2007) 0.98
Low dose aprotinin increases mortality and morbidity in coronary artery bypass surgery(*). J Res Med Sci (2012) 0.89
Childhood body mass index and adult pro-inflammatory and pro-thrombotic risk factors: data from the New Delhi birth cohort. Int J Epidemiol (2010) 0.85
Cerebrovascular disease in South Asia - Part II: Risk factors and prevention. JRSM Cardiovasc Dis (2012) 0.82
The Relationship of Metabolic Syndrome Traits with Beta-Cell Function and Insulin Sensitivity by Oral Minimal Model Assessment in South Asian and European Families Residing in the Netherlands. J Diabetes Res (2016) 0.75
Is hyperlipidemia a potential protective factor against intraoperative awareness in cardiac surgery? J Cardiothorac Surg (2016) 0.75
The genetics of haemostasis: a twin study. Lancet (2001) 8.08
Validation of a rapid whole blood test for diagnosing Helicobacter pylori infection. BMJ (1997) 5.80
RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response. Genes Immun (2002) 2.88
Plasminogen-activator inhibitor type 1 and coronary artery disease. N Engl J Med (2000) 2.32
Association between polymorphisms in the Clock gene, obesity and the metabolic syndrome in man. Int J Obes (Lond) (2007) 1.88
Effects of physiological concentrations of vasopressin on haemostatic function in man. Clin Sci (Lond) (1985) 1.64
Association of the platelet Pl(A) polymorphism of glycoprotein IIb/IIIa and the fibrinogen Bbeta 448 polymorphism with myocardial infarction and extent of coronary artery disease. Circulation (1997) 1.60
Diabetic retinopathy, promoter (4G/5G) polymorphism of PAI-1 gene, and PAI-1 activity in Pima Indians with type 2 diabetes. Diabetes Care (1997) 1.58
Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease. Blood (2000) 1.53
Angiotensin converting enzyme insertion/deletion genotype is associated with leukoaraiosis in lacunar syndromes. J Neurol Neurosurg Psychiatry (2002) 1.47
Elevation of plasma vasopressin in spontaneous migraine. Cephalalgia (1991) 1.44
The effect of exercise and heart rate on fibrinolytic activity. Blood Coagul Fibrinolysis (1992) 1.41
Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy. Diabetes (2001) 1.27
Heritability of features of the insulin resistance syndrome in a community-based study of healthy families. Diabet Med (2002) 1.16
Sertraline in children and adolescents with social anxiety disorder: an open trial. J Am Acad Child Adolesc Psychiatry (2001) 1.14
The influence of type 2 diabetes on fibrin structure and function. Diabetologia (2005) 1.11
The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure. Blood (2000) 1.08
A novel polymorphism in the factor XIII B-subunit (His95Arg): relationship to subunit dissociation and venous thrombosis. J Thromb Haemost (2005) 1.07
Identification of polymorphisms in the receptor for advanced glycation end products (RAGE) gene: prevalence in type 2 diabetes and ethnic groups. Diabetes (1998) 1.05
Molecular mechanisms involved in the resistance of fibrin to clot lysis by plasmin in subjects with type 2 diabetes mellitus. Diabetologia (2006) 1.04
Glutathione S-transferase M1 null genotype is associated with a decreased risk of myocardial infarction. FASEB J (2000) 1.04
Angiotensin-converting enzyme insertion/deletion polymorphism and cerebrovascular disease. Stroke (1996) 1.03
Soluble P-selectin levels, P-selectin polymorphisms and cardiovascular disease. J Thromb Haemost (2003) 1.00
Helicobacter pylori infection is related to atheroma in patients undergoing coronary angiography. Cardiovasc Res (1997) 1.00
Ethnic differences in cardiovascular risk factors in healthy Caucasian and South Asian individuals with the metabolic syndrome. J Thromb Haemost (2007) 1.00
alpha-fibrinogen Thr312Ala polymorphism and venous thromboembolism. Blood (2000) 1.00
Haemostatic responses and vasopressin release during colonoscopy in man. Clin Sci (Lond) (1991) 0.99
The UK Prospective Diabetes Study. Lancet (1998) 0.97
Neprilysin, obesity and the metabolic syndrome. Int J Obes (Lond) (2010) 0.96
The effect of blood coagulation factor XIII on fibrin clot structure and fibrinolysis. J Thromb Haemost (2014) 0.96
Apolipoprotein E polymorphism in cerebrovascular disease. Acta Neurol Scand (2000) 0.96
Association of a common polymorphism in the factor XIII gene with myocardial infarction. Thromb Haemost (1998) 0.96
A novel mechanism for hypofibrinolysis in diabetes: the role of complement C3. Diabetologia (2011) 0.95
Aspirin resistance and diabetes mellitus. Diabetologia (2008) 0.94
Effects of aspirin on clot structure and fibrinolysis using a novel in vitro cellular system. Arterioscler Thromb Vasc Biol (2009) 0.93
Genetic contribution to circulating levels of hemostatic factors in healthy families with effects of known genetic polymorphisms on heritability. Arterioscler Thromb Vasc Biol (2002) 0.93
Platelet GP IIIa PlA and GP Ib variable number tandem repeat polymorphisms and markers of platelet activation in acute stroke. Arterioscler Thromb Vasc Biol (1998) 0.93
Analysis of the tissue factor pathway inhibitor gene and antigen levels in relation to venous thrombosis. Br J Haematol (2001) 0.93
Environmental and genetic factors in relation to elevated circulating levels of plasminogen activator inhibitor-1 in Caucasian patients with non-insulin-dependent diabetes mellitus. Thromb Haemost (1995) 0.93
Activation of coagulation and fibrinolysis in open and laparoscopic cholecystectomy. Surg Endosc (1996) 0.92
False-positive autoantibodies in HIV infection. Lancet (1990) 0.92
Islet-cell antibodies and insulin autoantibodies in association with common viral infections. Lancet (1986) 0.92
Association of a common polymorphism in the factor XIII gene with venous thrombosis. Blood (1999) 0.91
Circulating levels of factor VII, fibrinogen, and von Willebrand factor and features of insulin resistance in first-degree relatives of patients with NIDDM. Circulation (1996) 0.91
Soluble vascular cell adhesion molecule-1 and E-selectin levels in relation to vascular risk factors and to E-selectin genotype in the first degree relatives of NIDDM patients and in NIDDM patients. Diabetologia (1998) 0.91
Levels of activated FXII in survivors of myocardial infarction--association with circulating risk factors and extent of coronary artery disease. Thromb Haemost (1998) 0.89
Type 2 diabetes: an atherothrombotic syndrome. Curr Mol Med (2005) 0.89
A study of human coagulation factor XIII A-subunit by electrospray ionisation mass spectrometry. Rapid Commun Mass Spectrom (2000) 0.89
von Willebrand factor and factor VIII: C in acute cerebrovascular disease. Relationship to stroke subtype and mortality. Thromb Haemost (1997) 0.88
Functional expression of glucose-dependent insulinotropic polypeptide receptors is coupled to differentiation in a human adipocyte model. Int J Obes (Lond) (2008) 0.88
Association of FXIII Val34Leu with decreased risk of myocardial infarction in Finnish males. Atherosclerosis (1999) 0.88
Sex differences in coagulation and fibrinolysis in white subjects with non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol (1996) 0.86
Risk factors for cerebrovascular disease and the role of coagulation and fibrinolysis. Blood Coagul Fibrinolysis (1995) 0.86
Plasminogen activator inhibitor-1 (PAI-1) promoter polymorphism and coronary artery disease in non-insulin-dependent diabetes. Thromb Haemost (1995) 0.86
FXII (46C-->T) polymorphism and in vivo generation of FXII activity--gene frequencies and relationship in patients with coronary artery disease. Thromb Haemost (1999) 0.85
Proinflammatory and hypofibrinolytic phenotype in healthy first-degree relatives of patients with Type 2 diabetes. J Thromb Haemost (2010) 0.85
The fibrinolytic response to ancrod therapy: characterization of fibrinogen and fibrin degradation products. Br J Haematol (1993) 0.85
Factor V Leiden gene mutation and thrombin generation in relation to the development of acute stroke. Arterioscler Thromb Vasc Biol (1995) 0.84
Subunit antigen and activity levels of blood coagulation factor XIII in healthy individuals. Relation to sex, age, smoking, and hypertension. Arterioscler Thromb Vasc Biol (1999) 0.84
Association of the platelet glycoprotein IIb HPA-3 polymorphism with survival after acute ischemic stroke. Stroke (1999) 0.84
Genetics of coronary heart disease: current knowledge and research principles. Am Heart J (2000) 0.84
Prevalence of three common polymorphisms in the A-subunit gene of factor XIII in patients with coronary artery disease. Thromb Haemost (1999) 0.84
Plasminogen activator inhibitor-1 promoter 4G/5G genotype and plasma levels in relation to a history of myocardial infarction in patients characterized by coronary angiography. Arterioscler Thromb Vasc Biol (1997) 0.84
Angiotensin-1-converting enzyme (ACE) gene polymorphism, plasma ACE levels, and their association with the metabolic syndrome and electrocardiographic coronary artery disease in Pima Indians. Metabolism (1998) 0.84
The influence of type 2 diabetes on fibrin clot properties in patients with coronary artery disease. Thromb Haemost (2014) 0.83
Factor XIII Val 34 Leu: a novel association with primary intracerebral hemorrhage. Stroke (1998) 0.83
The effect of insulin-induced hypoglycaemia on factor VIII:C concentrations and thrombin activity in subjects with type 1 (insulin-dependent) diabetes. Thromb Haemost (1995) 0.83
Gender-specific associations of the fibrinogen B beta 448 polymorphism, fibrinogen levels, and acute cerebrovascular disease. Arterioscler Thromb Vasc Biol (1997) 0.83
Angiotensin converting enzyme and angiotensin II type 1-receptor gene polymorphisms and risk of ischaemic heart disease. Cardiovasc Res (1999) 0.83
A search for candidate viruses in type 1 diabetic pancreas using the polymerase chain reaction. Diabet Med (1994) 0.83
The influence of Helicobacter pylori status on circulating levels of the coagulation factors fibrinogen, von Willebrand factor, factor VII, and factor VIII. Helicobacter (1996) 0.83
Metformin reduces C-reactive protein but not complement factor C3 in overweight patients with Type 2 diabetes mellitus. Diabet Med (2005) 0.83
Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphism and levels in subjects with cerebrovascular disease. Thromb Haemost (1997) 0.82
Sex differences in coagulation and fibrinolysis in subjects with coronary artery disease. Thromb Haemost (1998) 0.82
Polymorphisms of the factor VII gene and circulating FVII:C levels in relation to acute cerebrovascular disease and poststroke mortality. Stroke (1997) 0.81
Effect of physiological concentrations of vasopressin on components of the fibrinolytic system. Thromb Haemost (1989) 0.81
Alanine aminotransferase is associated with atherothrombotic risk factors in a British South Asian population. J Thromb Haemost (2008) 0.81
Fibrinolysis and diabetic retinopathy in NIDDM. Diabetes Care (1995) 0.81
Contrasting fibrinolytic responses in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes. Diabet Med (1991) 0.81
Association of the alpha-fibrinogen Thr312Ala polymorphism with poststroke mortality in subjects with atrial fibrillation. Circulation (1999) 0.81
A common coding polymorphism in the FXIII A-subunit gene (FXIIIVal34Leu) affects cross-linking activity. Thromb Haemost (1998) 0.81
The relationship between plasminogen activator inhibitor-1 and insulin resistance in newly diagnosed type 2 diabetes mellitus. Diabet Med (1993) 0.81
Rosiglitazone in Type 2 diabetes mellitus: an evaluation in British Indo-Asian patients. Diabet Med (2003) 0.80
Promoter (4G/5G) plasminogen activator inhibitor-1 genotype in Pima Indians: relationship to plasminogen activator inhibitor-1 levels and features of the insulin resistance syndrome. Diabetologia (1996) 0.80
Determinants of tPA antigen and associations with coronary artery disease and acute cerebrovascular disease. Thromb Haemost (1998) 0.80
Human endothelial cell-derived nuclear proteins that recognise polymorphic DNA elements in the von Willebrand factor gene promoter include YY1. Thromb Haemost (2001) 0.80
Plasma vasopressin levels in induced migraine attacks. Cephalalgia (1988) 0.80
The paraoxonase Gln-Arg 192 polymorphism in subjects with ischaemic heart disease. Coron Artery Dis (1998) 0.80
Coagulation factor XIII and cardiovascular disease in UK Asian patients undergoing coronary angiography. Thromb Haemost (2001) 0.80
Motivation and glycemic control in diabetes mellitus. J Psychosom Res (1997) 0.80
Polymorphisms of platelet glycoproteins in relation to macrovascular disease in type 2 diabetes mellitus. Diabet Med (1998) 0.80
Angiotensin converting enzyme (ACE) insertion/deletion (I/D) polymorphism, and diabetic retinopathy in subjects with IDDM and NIDDM. Diabet Med (1995) 0.79